Results 91 to 100 of about 3,001,542 (300)

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source

Finite element and mechanobiological modelling of vascular devices [PDF]

, 2011
There are two main surgical treatments for vascular diseases, (i) percutaneous stent deployment and (ii) replacement of an atherosclerotic artery with a vascular graft or tissue engineered blood vessel.
Zahedmanesh, Houman
core   +2 more sources

Mechanisms and therapeutic opportunities of the ribotoxic stress response in cancer

Molecular Oncology, EarlyView.
Cancer cells' high translational demand creates opportunities to therapeutically target ribosome function. Ribosome stalling and collisions activate ZAKα and the ribotoxic stress response (RSR), which can trigger rapid, p53‐independent apoptosis in cancer.
Anastassiya Kim, Maryam Aslam, Elouise Torruella, Alphons Sony, Asif Rahman, Simira Smith, Columba de la Parra, Moira Sauane   +7 more
wiley   +1 more source

Osteo-myocutanoeus flap: a novel flap for single toe amputation

Journal of Surgical Case Reports, 2010
Amputation is frequently required to treat wet gangrene secondary to peripheral vascular disease. Although different types of amputations have been reported, limited digital and ray amputation are the commonest amputations performed.
Jamie Murphy, Nadia Sciberras, Alan Wilson   +2 more
doaj  

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

Molecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira, Ana Teixeira‐Marques, Rui Freitas, João A Carvalho, Sara Monteiro‐Reis, Giorgio I. Russo, Rui Henrique, Carmen Jerónimo   +7 more
wiley   +1 more source

Editor's choice : European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on antithrombotic therapy for vascular diseases

, 2023
The European Society for Vascular Surgery (ESVS) has developed a series of clinical practice guidelines for clinicians caring for patients with vascular diseases. This is the first guideline specifically examining antithrombotic therapy.
ESVS Guideline Committee, [missing], Aboyans, V., Jilma, Bernd, Twine, C. P., Behrendt, C. A., Jilma, B., Nordanstig, Joakim,, Bellmunt-Montoya, S., Behrendt, Christian-Alexander, Nordanstig, Joakim, Twine, Christopher P., Reekers, Jim A., Baumgartner, Iris, Zlatanovic, Petar, Zlatanovic, P., Saratzis, Athanasios, Reekers, J. A., Wanhainen, Anders,, Saratzis, A., Kakkos, Stavros K., Vermassen, Frank, Kakkos, S. K., Baumgartner, I., ESVS Guidelines Committee, Aboyans, Victor, Bellmunt-Montoya, Sergi   +25 more
core   +1 more source

Extracellular matrix remodeling and immune reprogramming drive residual tumor progression of liver cancer after incomplete microwave ablation

Molecular Oncology, EarlyView.
Incomplete microwave ablation (iMWA) of liver cancer triggers a biphasic progression in residual tumors. At Day 3, the microenvironment is characterized by acute inflammatory responses and extracellular matrix (ECM) remodeling. By Day 14, a profound shift occurs toward oncogenic signal transduction and immunosuppression, marked by macrophage ...
Yu Liu, Yubei He, Nikolaus Berndt, Michael Mülleder, Kathrin Textoris‐Taube, Jing Guo, Matthias Stechele, Justus Ramtke, Shraga Nahum Goldberg, Lynn Jeanette Savic   +9 more
wiley   +1 more source

Vascular [PDF]

Operative Neurosurgery, 2019
Adam S, Arthur, I Josh, Abecassis, Karl R, Abi-Aad, Felipe C, Albuquerque, Rami O, Almefty, Rami James N, Aoun, Daniel L, Barrow, Joshua, Bederson, Bernard R, Bendok, Andrew F, Ducruet, Andrew A, Fanous, Vernard S, Fennell, Bruno C, Flores, Christoph J, Griessenauer, Louis J, Kim, Michael R, Levitt, William J, Mack, Justin, Mascitelli, Elliott, Min, J, Mocco, Simon, Morr, John D, Nerva, Alexandra E, Richards, Clemens M, Schirmer, Alfred P, See, Kenneth V, Snyder, Fucheng, Tian, Brian P, Walcott, Matthew E, Welz   +28 more
openaire   +2 more sources

The Opportunity for Impactful Integration of Vascular and Podiatric Care

, 2023
Background: The importance of collaboration between vascular and podiatric surgeons has been well-established. High-level partnerships are integral to the development of multidisciplinary programs and wound care centers, ultimately resulting in improved ...
Young Kim, Kevin W. Southerland
core   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

Molecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David, Arthur Karaulic, Audrey Bennetot, Clémence Fournier, Quentin Odet, Arthur Gouraud, Isabelle Bourget, Cédric Gaggioli, Sandy Giuliano, Frédéric Luciano, Olivier Léger, Zaki Sellam, Gilles Pagès   +12 more
wiley   +1 more source